Biomarkers have become essential in the diagnosis and treatment of cancer, so it’s no surprise there is a race underway to uncover more of them. Cancer biomarkers—which include inherited or acquired ...
A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track multiple gene mutations while simultaneously recording gene activity in ...
Gene Solutions, an innovative global biotechnology company advancing AI-powered multi-omics solutions for cancer detection ...
Colorectal cancer is among the most prevalent and lethal malignancies worldwide, with liver metastases occurring in nearly one-third of patients and accounting for a major share of cancer-related ...
Omics framework of colorectal cancer liver metastasis. Genomic, epigenetic, transcriptomic, proteomic, metabolomic, and microbiomic analyses were performed on tissue from primary colorectal cancer ...
Phase 1b study to assess the safety of neoadjuvant trifluridine/tipiracil with concurrent radiation in resectable stage II/III rectal cancer: Initial results of the FIERCE study. Complementary value ...
A new technology allows scientists to map, in single cells, the DNA binding sites of transcription factors and other ...
Predicting tumor recurrence at the molecular level emerges as a critical challenge, especially for patients with complex multi-omics profiles. Traditional prognostic models relying on single ...
Panome Bio, a leading multi-omics contract research organization (CRO) and CLIA-certified laboratory, and TD2 Oncology, a ...
On January 13th and 14th 2022, the Center for Translational Cancer Research organized the virtual third Indian Cancer Genome Atlas (ICGA) Conference 2022 “Biobanking to Omics – Collecting the Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results